2026 NPPES data Oral and Maxillofacial Pathology Dentistry NPI 1700862877 MD, DDS
Verify on CMS →

DAVID EFAW, MD, DDS

Oral and Maxillofacial Pathology Dentistry in BLOOMINGTON, Illinois. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
493
Medicare Part D claims · 234 beneficiaries · Oral and Maxillofacial Pathology Dentistry avg: 303
Industry payments
$256.59
10 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: DAVID EFAW, MD, DDS is a Oral and Maxillofacial Pathology Dentistry ([object Object]) practicing in BLOOMINGTON, Illinois with a Medicare Part D prescribing footprint of 493 claims across 234 beneficiaries . Industry payments of $256.59 across 10 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: DAVID EFAW, MD, DDS filed 493 Medicare Part D claims in 2023 across BLOOMINGTON, Illinois. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

DAVID EFAW, MD, DDS at a glance

Quality data not reported

NPI registry status

Active

Issued 12/20/2005

NPI 1700862877

Primary specialty

Oral and Maxillofacial Pathology Dentistry

Niche

690 US NPIs in this specialty

Medicare Part D claims

493 63% vs specialty avg

2023 prescription claims

Specialty avg: 303

Specialty distribution in Illinois

How Oral and Maxillofacial Pathology Dentistry compares to other specialties among Illinois providers

Illinois providers

Oral and Maxillofacial Pathology Dentistry share within Illinois

1. Oral and Maxillofacial Pathology Dentistry42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oral and Maxillofacial Pathology Dentistry share within Illinois

Specialty board-certification context

Estimated specialty board-certified rate — Oral and Maxillofacial Pathology Dentistry (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oral and Maxillofacial Pathology Dentistry ABMS/AOA estimate

Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DAVID EFAW, MD, DDS is a Oral and Maxillofacial Pathology Dentistry provider practicing in BLOOMINGTON, Illinois, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD, DDS. NPI: 1700862877. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DAVID EFAW, MD, DDS appears in the CMS NPPES registry as a Oral and Maxillofacial Pathology Dentistry provider holding MD, DDS credentials at 109 N REGENCY DR, BLOOMINGTON, IL, 61701, with a listed phone of (309) 663-2526. NPI 1700862877 was issued on 12/20/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what EFAW most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 493 prescription claims written by this provider, covering 234 Medicare beneficiaries and totaling roughly $3K in drug spend, with an opioid prescribing rate of 32.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oral and Maxillofacial Pathology Dentistry is a narrow specialty nationwide, with 690 enrolled providers across 48 states and an average of 303 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

109 N REGENCY DR
BLOOMINGTON, IL 61701

Provider Details

NPI 1700862877
Specialty Oral and Maxillofacial Pathology Dentistry
Credentials MD, DDS
Gender Male
NPI Issued 12/20/2005

Hospital and facility affiliations

Facilities where DAVID EFAW, MD, DDS bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CAPODICE EFAW OCHELTREE AND ELGER PLLC
BLOOMINGTON, IL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DAVID EFAW, MD, DDS. Source: openpaymentsdata.cms.gov.

Total received

$257

Largest payer

BioHorizons Implant Systems Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Illinois IDFPR 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 — they are NOT specific to DAVID EFAW, MD, DDS. To verify DAVID EFAW, MD, DDS's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases

IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

493
Total Claims
$3K
Total Drug Cost
234
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
495
Total Day Supply
4,041
Brand Drug Cost
$0
Generic Drug Cost
$3K
Opioid Claims
158 (32.0% rate)
Antibiotic Claims
211

Patient Demographics

Average Patient Age
72.9 years
Avg HCC Risk Score
0.99
Gender Split
58% female / 42% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Clindamycin Hcl
169
Chlorhexidine Gluconate
111
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
82
Tramadol Hcl
75
Cephalexin
15
Amoxicillin
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oral and Maxillofacial Pathology Dentistry Overview

How DAVID EFAW, MD, DDS fits within the Oral and Maxillofacial Pathology Dentistry landscape nationally.

690
Oral and Maxillofacial Pathology Dentistry Providers in US
48
States with Oral and Maxillofacial Pathology Dentistry
303
Avg Claims per Provider

DAVID EFAW, MD, DDS's 493 claims are above the specialty average of 303.

Nearby Oral and Maxillofacial Pathology Dentistry Providers in Illinois

Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as EFAW.

Compare Oral and Maxillofacial Pathology Dentistry nationally: see state-by-state distribution →

Frequently Asked Questions

What is DAVID EFAW, MD, DDS's specialty?
DAVID EFAW, MD, DDS specializes in Oral and Maxillofacial Pathology Dentistry and practices in BLOOMINGTON, Illinois. Credentials: MD, DDS.
How much does DAVID EFAW, MD, DDS prescribe under Medicare Part D?
In 2023, DAVID EFAW, MD, DDS wrote 493 Medicare Part D claims totaling $3K in drug costs for 234 beneficiaries.
Where is DAVID EFAW, MD, DDS located?
DAVID EFAW, MD, DDS is located at 109 N REGENCY DR, BLOOMINGTON, IL, 61701. Phone: (309) 663-2526.
What is DAVID EFAW, MD, DDS's NPI number?
DAVID EFAW, MD, DDS's National Provider Identifier (NPI) is 1700862877, issued on 12/20/2005.
Does DAVID EFAW, MD, DDS prescribe opioids?
Yes, DAVID EFAW, MD, DDS had 158 opioid claims in 2023 with an opioid prescribing rate of 32.0%.
How many Oral and Maxillofacial Pathology Dentistry providers are there in the US?
There are 690 Oral and Maxillofacial Pathology Dentistry providers across 48 states in the US. The average Oral and Maxillofacial Pathology Dentistry provider writes 303 Medicare Part D claims per year.
What drugs does DAVID EFAW, MD, DDS prescribe most often?
Based on 2023 Medicare Part D data, DAVID EFAW, MD, DDS's most frequently prescribed drugs include Clindamycin Hcl, Chlorhexidine Gluconate, Hydrocodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DAVID EFAW, MD, DDS accept Medicare?
DAVID EFAW, MD, DDS appears in CMS Medicare data with 493 Part D claims and 234 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DAVID EFAW, MD, DDS's credentials?
DAVID EFAW, MD, DDS's NPI is 1700862877 with credentials MD, DDS. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology